221 related articles for article (PubMed ID: 38064014)
1. Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.
Robles-Bañuelos B; Romo-Perez A; Dominguez-Gomez G; Chavez-Blanco A; Gonzalez-Fierro A; Duenas-Gonzalez A
Clin Transl Oncol; 2024 May; 26(5):1077-1088. PubMed ID: 38064014
[TBL] [Abstract][Full Text] [Related]
2. Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik I; Ramachandran S; Prasad S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing in cancer.
Sleire L; Førde HE; Netland IA; Leiss L; Skeie BS; Enger PØ
Pharmacol Res; 2017 Oct; 124():74-91. PubMed ID: 28712971
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
Saengboonmee C; Sanlung T; Wongkham S
Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
7. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
8. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics.
Singhal S; Maheshwari P; Krishnamurthy PT; Patil VM
Anticancer Agents Med Chem; 2022 Aug; 22(15):2726-2756. PubMed ID: 35301945
[TBL] [Abstract][Full Text] [Related]
9. Overcoming cancer therapeutic bottleneck by drug repurposing.
Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
11. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
12. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
[TBL] [Abstract][Full Text] [Related]
14. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of FDA-approved drugs against cancer - focus on metastasis.
Ozsvári B; Lamb R; Lisanti MP
Aging (Albany NY); 2016 Apr; 8(4):567-8. PubMed ID: 27038638
[No Abstract] [Full Text] [Related]
16. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
18. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
19. Targeting ion channels for cancer therapy by repurposing the approved drugs.
Kale VP; Amin SG; Pandey MK
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2747-55. PubMed ID: 25843679
[TBL] [Abstract][Full Text] [Related]
20. New drugs are not enough‑drug repositioning in oncology: An update.
Armando RG; Mengual Gómez DL; Gomez DE
Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]